Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

25/09/2026

Aggiornamento "Diario di bordo sulla Trasparenza"

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

14/09/2026

Newsletter Disuguaglianze di salute n.56

Agendas and minutes

24/09/2026

PDCO minutes of the 21-24 July 2026 meeting

Consumer Updates RSS Feed

15/09/2026

The Facts on Tampons and Tampon Safety

Regulatory and procedural guidelines (human and veterinary)

24/09/2026

Member states contact points for review of national implementation of quick response (QR) codes of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised procedures (DCP) and national procedures

Scientific guidelines (human and veterinary)

24/09/2026

Draft guideline on the clinical requirements for medicines intended for the treatment of sickle cell disease

Paediatric investigation plans

04/09/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyclarys, omaveloxolone, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000338563

Orphan designations

26/08/2026

Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn

New medicines and opinions: human

18/09/2026

Human medicines European public assessment report (EPAR): Adcomfo, omalizumab, Status: Opinion

MedWatch Safety Alerts RSS Feed

25/09/2026

Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters

What's New: Drugs RSS Feed

25/09/2026

Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis